Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients-Reference-Cited by-同舟云学术

Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients

Published:2017-09 Issue:9 Volume:101 Page:2133-2138
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

David-Neto Elias,Agena Fabiana,Ramos Fernanda,Triboni Ana Heloisa Kamada,Romano Paschoalina,de Almeida Rezende Ebner Persio,Coelho Venceslau,Galante Nelson Zocoler,Lemos Francine Brambate Carvalhinho

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference28 articles.

1. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients;Chan;Transplantation,2010

2. Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications;Kovarik;Clin Pharmacol Ther,2001

3. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine;Kovarik;Clin Pharmacol Ther,2001

4. Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation;Kovarik;Am J Transplant,2003

5. Influence of hepatic impairment on everolimus pharmacokinetics: implications for dose adjustment;Kovarik;Clin Pharmacol Ther,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression for older liver transplant recipients;Transplantation Reviews;2024-01

2. The impact of mTOR inhibitors in the regression of left ventricular hypertrophy in elderly kidney transplant recipients;Clinical Transplantation;2022-06-17

3. No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration–Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus;Transplantation Proceedings;2022-03

4. Immunosuppression Considerations for Older Kidney Transplant Recipients;Current Transplantation Reports;2021-04-06

5. Pharmacokinetics of Enteric-Coated Mycophenolate Sodium Metabolites in Patients Over 60 Years Old Within the First Year After Renal Transplantation;Transplantation Proceedings;2021-04